- Politics
- Diversity, equity and inclusion
- Financial Decision Making
- Telehealth
- Patient Experience
- Leadership
- Point of Care Tools
- Product Solutions
- Management
- Technology
- Healthcare Transformation
- Data + Technology
- Safer Hospitals
- Business
- Providers in Practice
- Mergers and Acquisitions
- AI & Data Analytics
- Cybersecurity
- Interoperability & EHRs
- Medical Devices
- Pop Health Tech
- Precision Medicine
- Virtual Care
- Health equity
Podcast: A Closer Look at Pear Therapeutics
CEO of Pear Therapeutics, Corey McCann, M.D., Ph.D., speaks to hosts Samara and Paul about digital therapeutics and what is happening with Pear.
Digital therapeutics offer patients an alternate treatment method to manage physical, mental and behavioral conditions. As the industry continues to grow, it is important for both patients and health systems alike to understand the different companies who offer such treatments.
At HLTH2019 in Las Vegas, Nevada, hosts of Data Book Samara Rosenfeld and Paul Abrams, MBA, sat down with Corey McCann, M.D., Ph.D., president and CEO of Pear Therapeutics.
McCann discussed Pear’s prescription-based digital therapeutics, reSET and reSET-O, the direction the company is going in moving forward and the company’s split from Sandoz.
Make sure to follow Samara and Paul on Twitter and let us know who else you want to hear from this season.
Get the best insights in digital health directly to your inbox.
Binge More Data Book
Healthy Bottom Line: The Critical Need for Better Communication, Price Transparency in Healthcare
November 30th 2021Mark Spinner, CEO of AccessOne, discusses some of the financing concerns that patients expressed in a recent AccessOne survey as well as some solutions that hospitals and health systems can implement to improve communication and price transparency.
